Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancers|April 3, 2020
Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)Santa Cirmi, Asmae El Abd, Louis Letinier, et al.
Pharmacological Research|August 10, 2016
Pharmacological treatments of cardiovascular diseases: Evidence from real-life studiesFrancesco Salvo, Julien Bezin, Pauline Bosco-Levy, et al.
Clinical and Translational Science|March 4, 2022
Emergency department admissions induced by drug-drug interactions in the elderly: A cross-sectional studyLouis Letinier, Iris Pujade, Perrine Duthoit, et al.
BMC Cancer|October 8, 2016
PRognostic factor of Early Death In phase II Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model)Thomas Grellety, Sophie Cousin, Louis Letinier, et al.
Fundamental & Clinical Pharmacology|February 23, 2022
Psychoactive substance use among students: A cross-sectional analysisJustine Perino, Marie Tournier, Clément Mathieu, et al.
Drug Safety|January 6, 2026
Standardizing and Comparing Management Recommendations for Potential Drug-Drug Interactions Across Different Interaction CheckersLelio Crupi, Louis Letinier, Vianney Jouhet, et al.
Therapie|December 26, 2022
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?Antoine Pariente, Joëlle Micallef, Amir Lahouegue, et al.
Fundamental & Clinical Pharmacology|May 13, 2020
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemicLouis Larrouquere, Manon Gabin, Emmanuelle Poingt, et al.
Pageof 1